Her Campus Logo Her Campus Logo

Let’s Talk About the COVID-19 Vaccines

As 2020 came to an end, the world was overjoyed that the year was over. Unfortunately, many of the problems that arose during 2020 didn’t end with the year. This includes the COVID-19 pandemic that is raging through many countries with little hope that it will be ending anytime soon. The majority of the world masked up, washed their hands, kept their distance, and isolated themselves after potentially risky encounters. While it is proving to be very controversial, a few different pharmaceutical companies have developed a vaccine in order to combat infection of the virus in hopes to eventually create a general immunity to the virus. Let’s talk about what the vaccine is, how it works, and the risks. I have interviewed a few people who have already received the vaccine in order to educate others about what the experience was like and how they felt afterward.

[bf_image id="qfj8xh44n43gf75wh8mthg7"]

The Four W’s of the Vaccine

Who produced the COVID-19 vaccine? Two different pharmaceutical companies have produced an FDA approved vaccine to fight the virus. The Pfizer-BioNTech created the first vaccine. On the CDC’s page surrounding the Pfizer-BioNTech vaccine, it has a list of common allergens that are NOT included in the vaccine. It is recommended to people about the age of sixteen years old. It also includes information on the shot and how it is administered. This vaccine consists of two doses that are twenty-one days apart. The other company that has developed a vaccine is Moderna. This page also includes a list of common allergens that the vaccine does not include. One major difference is the age group the vaccine is recommended for. Instead of being recommended for anyone sixteen or up, the Moderna vaccine is recommended for people over eighteen. Another difference is in the days in between shots. The Moderna vaccine’s second dose is administered “one month (28 days) apart.” (CDC).

What is the COVID vaccine? The CDC describes the COVID-19 vaccine as a “messenger RNA or mRNA” (CDC), which means that the vaccine uses mRNA to create a protein that your immune systems then respond to. When the immune system recognizes this protein, it produces antibodies that are able to protect us from being infected by the virus in the future. Specifically, with the COVID-19 vaccine, that protein is known as the “spike protein… [which] is found on the surface of the virus that causes COVID-19” (CDC). The red parts of the picture below are the spike proteins. [bf_image id="83hf42gf7g6jwnnjrtzvmms"]

What did development look like? A big controversy surrounding the virus is its development. The development of the vaccine began with the implementation of “Operation Warp Speed (OWS),” (Biospace) in March of 2020. Operation Warp Speed funded pharmaceutical companies to research and develop a vaccine. This money also aided in clinical trials. By July, clinical trials were being conducted during the vaccine’s development. Two phases of trials were conducted before entering the third phase of clinical trials which tested the vaccine on humans. The first vaccine to receive approval was the Pfizer-BioNTech vaccine. It received its approval in December of 2020. Upon its approval and the active state of emergency that the United States is in, administration of the vaccine began within twenty-four hours. Though the development of the vaccine was quick, in comparison to other vaccines, the vaccine has had incredibly high success rates.

What is the success rate? Both vaccines have an “efficacy rate of approximately 95%,” (Biospace). The Pfizer-BioNTech trials revealed that out of everyone included in their clinical trial, less than 200 people total contacted COVID-19 after receiving the vaccine, “162 of them occurring in the placebo,” (Biospace) patients. Similarly, to the Moderna vaccine, after receiving the vaccine, “only eleven [cases] compared to the 185 cases in the placebo,” (Biospace) patients. On top of that, less than two percent of patients have had harmful negative reactions.

Real-Life Application of the Vaccine

The COVID-19 pandemic has taken the world by storm. Since the vaccine’s approvals in the US and in many other countries, there have been “more than 32.4 million doses,” (Bloomberg) administered. Roughly 10 million have been given in the US alone. The distribution of the vaccine in the US is based on the risk of an individual. It started with healthcare personnel and people in long term care facilities. These people are deemed more at risk due to their exposure levels and their ability to fight off the virus. The second wave will administer vaccines to people who are frontline and/or essential workers and people who are over seventy-five years old. As more vaccines are created more and more people will have access to the vaccine. By getting the vaccine, people are creating a greater chance for herd immunity. “Herd immunity is a term used to describe when enough people have protection—either from previous infection or vaccination—that it is unlikely a virus or bacteria can spread and cause disease,” (CDC) the number of people that will need to receive the vaccine to create this immunity is unknown. But by more people getting it, we get closer to that point. 

[bf_image id="6kkx2crprrhv94nw4ws933cg"]  I have talked to three people that I know who have received the vaccine. I asked them about their experience and why they chose to get the vaccine. I probably annoyed them with the number of questions that I asked them, but they were willing to share their experience to get the word out about the vaccine and what it’s really like. These people are of different ages, received the vaccine at different times, are in different states and one of them has even received both doses. Nicole is a recent college graduate who was vaccinated recently. She has yet to receive the second dose though. In her experience, she was in and out within an hour. She described the healthcare workers as “pros” and she cannot emphasize enough, "how nice the staff was. They answered any questions or concerns I had about the vaccine.” She continued with what the aftereffects of the vaccine were. She described common side effects among any vaccine such as muscle soreness where the vaccine was injected, “I did have a headache the morning after the injection. I took some ibuprofen and went about my day.” I asked her if she would recommend it to anyone, she replied “I didn’t get the vaccine for myself. I got it for my coworkers and their families. I want to know that I’m not infecting anyone else.” I asked another young adult who received the Pfizer-BioNTech vaccine and he describes a very similar experience, “after I received my vaccine, I was monitored for fifteen minutes to make sure there were no reactions. Then I was given a card with some information including the day I need to return for the second dose.” He said the shot was at the same level of pain as any other shot he’s gotten. On a scale of one to ten he described the pain as a one or a two max. Other than that, he said he’s hasn’t “experienced any side effects.”

Heidi is a Mental Healthcare Worker. “I chose to get be vaccinated because I have not seen my elderly parents for the last ten months due to the social distance protocols.” She has received both doses of the vaccine and told me about both experiences. She walked into the clinic, checked in, received a symptom check, and then was called back for the injection. She also had to wait for fifteen minutes after injection to make sure that there were no adverse effects. “The first shot was not painful at all and my arm wasn’t affected. The second was moderately painful and I did have a great deal of muscle pain in my arm for about an hour,” she continued with “on a scale of one to ten, I would say the first one was a one and the second one was a five.” With the first injection, she felt zero side effects. She felt healthy and normal. After receiving the second one, she said that she had muscle pain in her arm and chest for a few days with a headache on top, but eventually they subsided, “by the third day after the second injection I was back to work and fine.” After a few days of pain, she is not only protected from contracting COVID-19. She is now able to help her clients in a much safer environment.

[bf_image id="nk5q8qf4tvhjq6ks448fqm3s"] It is important for us as Americans, humans even, to take care of each other. Scientists have dedicated countless hours; healthcare workers haven’t been given a break in almost a year. We have to do what we can to protect each other and stop the spread. Millions of people around the world have died from COVID-19 and there’s a chance to do something about it. Do what’s best for you, but please consider protecting yourselves and others with the vaccine. 







My name is Gwenevere Ash, I am an English Major at Central Washington University. I have a cat named Luci and I love Parks and Recreation.
Similar Reads👯‍♀️